Inhibitor Therapeutics, Inc.

INTIReported to SECin USCIK 0001042418Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5
Form 4 lines at Inhibitor Therapeutics, Inc., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
Black Robe Capital LLC—Giftnothing paid3,200,000 sharesAug 4, 2026Black Robe Capital LLCnothing paidGift · Aug 4Gift3,200,000Aug 4, 2026
OSMAN RONALD E—Awardnothing paid50,000 sharesAug 4, 2026OSMAN RONALD Enothing paidAward · Aug 4Award50,000Aug 4, 2026
Yanez Michelle—Awardnothing paid50,000 sharesAug 4, 2026Yanez Michellenothing paidAward · Aug 4Award50,000Aug 4, 2026
SEARS SAMUEL P JR—Awardnothing paid50,000 sharesAug 4, 2026SEARS SAMUEL P JRnothing paidAward · Aug 4Award50,000Aug 4, 2026
ODONNELL FRANCIS E JRChief Executive OfficerAwardnothing paid50,000 sharesAug 4, 2026ODONNELL FRANCIS E JRChief Executive Officernothing paidAward · Aug 4Award50,000Aug 4, 2026